Cwm LLC bought a new stake in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 202,391 shares of the software maker’s stock, valued at approximately $2,583,000.

A number of other institutional investors also recently added to or reduced their stakes in MDRX. Oregon Public Employees Retirement Fund raised its stake in Allscripts Healthcare Solutions by 4.3% in the second quarter. Oregon Public Employees Retirement Fund now owns 68,182 shares of the software maker’s stock worth $870,000 after buying an additional 2,826 shares in the last quarter. Virtu Financial LLC purchased a new stake in shares of Allscripts Healthcare Solutions during the second quarter worth about $134,000. Bank of Montreal Can raised its stake in shares of Allscripts Healthcare Solutions by 6.9% in the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock worth $135,000 after buying an additional 689 shares in the last quarter. North Star Asset Management Inc. raised its stake in shares of Allscripts Healthcare Solutions by 7.6% in the first quarter. North Star Asset Management Inc. now owns 623,873 shares of the software maker’s stock worth $7,911,000 after buying an additional 44,115 shares in the last quarter. Finally, FNY Partners Fund LP raised its stake in shares of Allscripts Healthcare Solutions by 900.0% in the first quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock worth $101,000 after buying an additional 7,200 shares in the last quarter.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) traded down 1.22% during trading on Tuesday, hitting $12.17. The stock had a trading volume of 104,949 shares. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $15.17. The stock’s market capitalization is $2.21 billion. The company has a 50-day moving average of $12.13 and a 200-day moving average of $11.85.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its quarterly earnings data on Thursday, May 4th. The software maker reported $0.10 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.09 by $0.01. Allscripts Healthcare Solutions had a positive return on equity of 5.75% and a negative net margin of 2.93%. The company had revenue of $415 million for the quarter, compared to the consensus estimate of $415.20 million. During the same quarter last year, the business posted $0.13 earnings per share. The firm’s revenue was up 20.1% compared to the same quarter last year. On average, equities analysts expect that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current fiscal year.

WARNING: “Cwm LLC Purchases New Position in Allscripts Healthcare Solutions, Inc. (MDRX)” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.dailypolitical.com/2017/07/18/cwm-llc-purchases-new-position-in-allscripts-healthcare-solutions-inc-mdrx.html.

A number of equities research analysts recently issued reports on the company. Bank of America Corporation assumed coverage on Allscripts Healthcare Solutions in a research report on Monday, May 15th. They issued a “neutral” rating and a $14.00 target price on the stock. Cantor Fitzgerald reissued a “neutral” rating and issued a $13.00 target price on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Leerink Swann lowered Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and dropped their target price for the company from $15.00 to $13.00 in a research report on Monday, June 19th. BidaskClub raised Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, June 24th. Finally, Piper Jaffray Companies dropped their target price on Allscripts Healthcare Solutions from $15.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 22nd. One analyst has rated the stock with a sell rating, ten have given a hold rating and ten have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $14.74.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total transaction of $301,500.00. Following the sale, the president now owns 412,488 shares in the company, valued at $4,974,605.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.75% of the company’s stock.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.